Show simple item record

Files in this item

Thumbnail

Item metadata

dc.contributor.authorVasou, Andri
dc.contributor.authorNightingale, Katie
dc.contributor.authorCetkovská , Vladimira
dc.contributor.authorScheler, Jonathan
dc.contributor.authorBamford, Conor G. G.
dc.contributor.authorAndrejeva, Jelena
dc.contributor.authorRowe, Jessica C.
dc.contributor.authorSwatek, Kirby N.
dc.contributor.authorSchwarz-Linek, Ulrich
dc.contributor.authorRandall, Richard E.
dc.contributor.authorMcLauchlan, John
dc.contributor.authorWeekes, Michael P.
dc.contributor.authorBogunovic, Dusan
dc.contributor.authorHughes, David J.
dc.date.accessioned2025-02-17T10:30:27Z
dc.date.available2025-02-17T10:30:27Z
dc.date.issued2025-02-11
dc.identifier313643056
dc.identifierf2a583f9-9386-4b6c-adfb-84a0668fecbc
dc.identifier.citationVasou , A , Nightingale , K , Cetkovská , V , Scheler , J , Bamford , C G G , Andrejeva , J , Rowe , J C , Swatek , K N , Schwarz-Linek , U , Randall , R E , McLauchlan , J , Weekes , M P , Bogunovic , D & Hughes , D J 2025 , ' ISG15-dependent stabilisation of USP18 is necessary but not sufficient to regulate type I interferon signalling in humans ' , European Journal of Immunology , vol. 55 , no. 2 , e202451651 . https://doi.org/10.1002/eji.202451651en
dc.identifier.issn0014-2980
dc.identifier.otherORCID: /0000-0002-9304-6678/work/178723950
dc.identifier.otherORCID: /0000-0003-0526-223X/work/178724469
dc.identifier.otherORCID: /0000-0002-0090-5710/work/178724879
dc.identifier.urihttps://hdl.handle.net/10023/31395
dc.descriptionFunding: This work was supported by grants from the Academy of Medical Sciences (SBF003/1028 to DJH), Wellcome Trust Institutional Strategic Support Fund (to DJH), Wellcome Trust (101788/Z/13/Z to RER), the UK Medical Research Council (MC_UU_12014/1 to JM and CGGB) and by the Wellcome Trust via a Senior Clinical Research Fellowship (108070/Z/15/Z to MPW). The UK Medical Research Council (MC_UU_00038/8 to KNS). KNS is a Lister Institute Prize Fellow.en
dc.description.abstractType I interferon (IFN) signalling induces the expression of several hundred IFN-stimulated genes (ISGs) that provide an unfavourable environment for viral replication. To prevent an overexuberant response and autoinflammatory disease, IFN signalling requires tight control. One critical regulator is the ubiquitin-like protein IFN-stimulated gene 15 (ISG15), evidenced by autoinflammatory disease in patients with inherited ISG15 deficiencies. Current models suggest that ISG15 stabilises ubiquitin-specific peptidase 18 (USP18), a well-established negative regulator of IFN signalling. USP18 also functions as an ISG15-specific peptidase that cleaves ISG15 from ISGylated proteins; however, USP18's catalytic activity is dispensable for controlling IFN signalling. Here, we show that the ISG15-dependent stabilisation of USP18 involves hydrophobic interactions reliant on tryptophan 123 (W123) in ISG15. Nonetheless, while USP18 stabilisation is necessary, it is not sufficient for the regulation of IFN signalling; ISG15 C-terminal mutants with significantly reduced affinity still stabilised USP18, yet the magnitude of signalling resembled ISG15-deficient cells. Hence, USP18 requires non-covalent interactions with the ISG15 C-terminal diGlycine motif to promote its regulatory function. It shows ISG15 is a repressor of type I IFN signalling beyond its role as a USP18 stabiliser.
dc.format.extent16
dc.format.extent2840322
dc.language.isoeng
dc.relation.ispartofEuropean Journal of Immunologyen
dc.rights© 2025 The Author(s). This is an open access article under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.en
dc.subjectAutoinflammatory diseaseen
dc.subjectInterferon-stimulated genesen
dc.subjectInterferonopathyen
dc.subjectISG15en
dc.subjectType I IFN signallingen
dc.subjectUSP18en
dc.subjectDASen
dc.subjectMCCen
dc.titleISG15-dependent stabilisation of USP18 is necessary but not sufficient to regulate type I interferon signalling in humansen
dc.typeJournal articleen
dc.contributor.sponsorAcademy of Medical Sciencesen
dc.contributor.sponsorThe Wellcome Trusten
dc.contributor.institutionUniversity of St Andrews.School of Biologyen
dc.contributor.institutionUniversity of St Andrews.Biomedical Sciences Research Complexen
dc.identifier.doi10.1002/eji.202451651
dc.description.statusPeer revieweden
dc.identifier.grantnumberSBF003/1028en
dc.identifier.grantnumber101788/Z/13/Zen


This item appears in the following Collection(s)

Show simple item record